Karyopharm Therapeutics Inc. (KPTI): Price and Financial Metrics

KPTI POWR Grades

• KPTI scores best on the Growth dimension, with a Growth rank ahead of 88.81% of US stocks.
• KPTI's strongest trending metric is Quality; it's been moving down over the last 161 days.
• KPTI's current lowest rank is in the Stability metric (where it is better than 1.7% of US stocks).

KPTI Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for KPTI is -0.94 -- better than only 4.01% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -5.69 for Karyopharm Therapeutics Inc; that's greater than it is for only 2.36% of US stocks.
• In terms of volatility of its share price, KPTI is more volatile than 85.26% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to Karyopharm Therapeutics Inc, a group of peers worth examining would be KMPH, ICPT, BYSI, INSM, and RDUS.
• KPTI's SEC filings can be seen here. And to visit Karyopharm Therapeutics Inc's official web site, go to www.karyopharm.com.

KPTI Valuation Summary

• In comparison to the median Healthcare stock, KPTI's EV/EBIT ratio is 108.87% lower, now standing at -2.6.
• KPTI's EV/EBIT ratio has moved up 18.3 over the prior 95 months.
• Over the past 95 months, KPTI's price/sales ratio has gone down 1018.6.

Below are key valuation metrics over time for KPTI.

KPTI Growth Metrics

The 4 year net cashflow from operations growth rate now stands at -74.5%.
• Its 5 year cash and equivalents growth rate is now at 377.93%.
• The 4 year net income to common stockholders growth rate now stands at -56.38%.

KPTI's revenue has moved up $118,400,000 over the prior 67 months.

The table below shows KPTI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	118.65	-163.225	-206.229
2021-06-30	102.294	-183.582	-207.912
2021-03-31	113.207	-168.111	-200.756
2020-12-31	108.085	-160.234	-196.273
2020-09-30	91.081	-169.089	-201.499
2020-06-30	82.897	-161.283	-189.371

KPTI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• KPTI has a Quality Grade of C, ranking ahead of 58.11% of graded US stocks.
• KPTI's asset turnover comes in at 0.338 -- ranking 138th of 681 Pharmaceutical Products stocks.
• CAPR, DRNA, and PLXP are the stocks whose asset turnover ratios are most correlated with KPTI.

The table below shows KPTI's key quality metrics over time.